Xilin Zhou

638 total citations
18 papers, 382 citations indexed

About

Xilin Zhou is a scholar working on Economics and Econometrics, Endocrinology, Diabetes and Metabolism and General Health Professions. According to data from OpenAlex, Xilin Zhou has authored 18 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in General Health Professions. Recurrent topics in Xilin Zhou's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Diabetes Management and Education (4 papers) and Diabetes Management and Research (4 papers). Xilin Zhou is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Diabetes Management and Education (4 papers) and Diabetes Management and Research (4 papers). Xilin Zhou collaborates with scholars based in United States and China. Xilin Zhou's co-authors include Ping Zhang, Xuanping Zhang, Krista K. Proia, Boon Peng Ng, Ann Albright, Karen R. Siegel, Edward W. Gregg, Mohammed K. Ali, Sundar S. Shrestha and Guijing Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Xilin Zhou

16 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xilin Zhou United States 9 147 91 77 70 60 18 382
Thomas Godec United Kingdom 10 118 0.8× 83 0.9× 29 0.4× 28 0.4× 75 1.3× 24 383
Claire L. Le Guen United States 8 71 0.5× 51 0.6× 119 1.5× 36 0.5× 81 1.4× 11 607
Thaddäus Tönnies Germany 13 230 1.6× 94 1.0× 77 1.0× 22 0.3× 53 0.9× 35 492
James C. Capretta United States 4 180 1.2× 140 1.5× 61 0.8× 36 0.5× 37 0.6× 9 427
Adrienne Faerber United States 10 97 0.7× 42 0.5× 30 0.4× 31 0.4× 44 0.7× 16 384
Elizabeth Kern United States 11 68 0.5× 40 0.4× 35 0.5× 18 0.3× 22 0.4× 21 438
Minsun Kang South Korea 10 65 0.4× 53 0.6× 27 0.4× 21 0.3× 21 0.3× 24 400
Calvin Ke Canada 11 364 2.5× 95 1.0× 51 0.7× 22 0.3× 86 1.4× 33 573
Arthur Asirvatham India 9 247 1.7× 49 0.5× 30 0.4× 18 0.3× 53 0.9× 27 434
William W. Quick United States 6 306 2.1× 117 1.3× 101 1.3× 64 0.9× 38 0.6× 8 587

Countries citing papers authored by Xilin Zhou

Since Specialization
Citations

This map shows the geographic impact of Xilin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilin Zhou more than expected).

Fields of papers citing papers by Xilin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xilin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilin Zhou. The network helps show where Xilin Zhou may publish in the future.

Co-authorship network of co-authors of Xilin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xilin Zhou. A scholar is included among the top collaborators of Xilin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xilin Zhou. Xilin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Tang, Shichao, Yu Wang, Xilin Zhou, & Ping Zhang. (2025). National trends in per-capita medical expenditures among U.S. adults with diabetes, 2000–2022. Diabetes Research and Clinical Practice. 223. 112154–112154.
3.
4.
Zhou, Xilin, Linda J. Andes, Deborah B. Rolka, & Giuseppina Imperatore. (2023). Changes in Healthcare Utilization Among Medicare Beneficiaries With Diabetes 2 Years Into the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 2(3). 100117–100117. 4 indexed citations
5.
Zhou, Xilin, et al.. (2023). Income-related inequalities in diagnosed diabetes prevalence among US adults, 2001−2018. PLoS ONE. 18(4). e0283450–e0283450. 19 indexed citations
6.
Robles, Andrew J., Xin Zhang, Xilin Zhou, et al.. (2022). Design, Synthesis, and Biological Evaluation of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines as Microtubule Targeting Agents. Molecules. 27(1). 321–321. 8 indexed citations
7.
Barrett, Catherine, Xilin Zhou, Isabel García Méndez, et al.. (2022). Prevalence of Mental, Behavioral, and Developmental Disorders Among Children and Adolescents with Diabetes, United States (2016–2019). The Journal of Pediatrics. 253. 25–32. 4 indexed citations
8.
Zhang, Ping, et al.. (2021). High Out-of-pocket Health Care Cost Burden Among Medicare Beneficiaries With Diabetes, 1999–2017. Diabetes Care. 44(8). 1797–1804. 18 indexed citations
9.
Chen, Yu, et al.. (2021). 326-OR: Income-Related Inequalities in Diagnosed Diabetes Prevalence among U.S. Adults, 2001-2018. Diabetes. 70(Supplement_1). 2 indexed citations
10.
Zhou, Xilin, Sundar S. Shrestha, Hui Shao, & Ping Zhang. (2020). Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005–2007 and 2015–2017. Diabetes Care. 43(10). 2396–2402. 35 indexed citations
11.
Siegel, Karen R., Mohammed K. Ali, Xilin Zhou, et al.. (2020). Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?. Diabetes Care. 43(7). 1557–1592. 95 indexed citations
12.
Zhou, Xilin, Karen R. Siegel, Boon Peng Ng, et al.. (2020). Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care. 43(7). 1593–1616. 85 indexed citations
13.
Hu, Zhiping, Kun Qian, Xilin Zhou, et al.. (2020). [Prevalence and risk factors of Blastocystis hominis infections among AIDS patients in Nanchang City].. PubMed. 32(6). 577–583. 1 indexed citations
14.
15.
Zhou, Xilin, Sundar S. Shrestha, Elizabeth T. Luman, Guijing Wang, & Ping Zhang. (2017). Medical Expenditures Associated With Diabetes in Myocardial Infarction and Ischemic Stroke Patients. American Journal of Preventive Medicine. 53(6). S190–S196. 8 indexed citations
16.
Wang, Guijing, Xilin Zhou, Xiaohui Zhuo, & Ping Zhang. (2017). Annual Total Medical Expenditures Associated with Hypertension by Diabetes Status in U.S. Adults. American Journal of Preventive Medicine. 53(6). S182–S189. 32 indexed citations
17.
Zhou, Xilin. (2012). Synthesis of bicyclic thieno[2,3-d]pyrimidines, tricyclic thieno[2,3-d]pyrimidines and thieno[3,2-d]pyrimidines as classical and nonclassical antifolates.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Godec Breakdown of academic impact, for papers by Claire L. Le Guen Breakdown of academic impact, for papers by Thaddäus Tönnies Breakdown of academic impact, for papers by James C. Capretta Breakdown of academic impact, for papers by Adrienne Faerber Breakdown of academic impact, for papers by Elizabeth Kern Breakdown of academic impact, for papers by Minsun Kang Breakdown of academic impact, for papers by Calvin Ke Breakdown of academic impact, for papers by Arthur Asirvatham Breakdown of academic impact, for papers by William W. Quick
Rankless by CCL
2026